Evidence map›Paper›PMID 35295767›Full record

ArticleJHEP reports : innovation in hepatology2022

Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B.

Nicholas van Buuren, Ricardo Ramirez, Cameron Soulette, Vithika Suri, Dong Han, Lindsey May, Scott Turner, P C Parvangada, Ross Martin, Henry L Y Chan and 8 more

Open access · goldAbstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. [Clinical significance and occurrence mechanism of hepatitis B virus DNA integration].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Indeterminate Phase/Grey Zone of Chronic Hepatitis B: Clinical Features, Outcomes and Molecular Insights.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Hepatitis B virus integration and hepatocarcinogenesis.Liver research (Beijing, China) · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 4 countries.

Nicholas van BuurenGilead Sciences Inc., Foster City, CA, USA.
Ricardo RamirezGilead Sciences Inc., Foster City, CA, USA.
Cameron SouletteGilead Sciences Inc., Foster City, CA, USA.
Vithika SuriGilead Sciences Inc., Foster City, CA, USA.
Dong HanGilead Sciences Inc., Foster City, CA, USA.
Lindsey MayGilead Sciences Inc., Foster City, CA, USA.
Scott TurnerGilead Sciences Inc., Foster City, CA, USA.
P C ParvangadaGilead Sciences Inc., Foster City, CA, USA.
Ross MartinGilead Sciences Inc., Foster City, CA, USA.
Henry L Y ChanThe Chinese University of Hong Kong, Hong Kong SAR, China.
Patrick MarcellinHôpital Beaujon, Clichy, University of Paris, Paris, France.
Maria ButiHospital Universitari Vall d'Hebron, Barcelona, Spain.
Nam BuiGilead Sciences Inc., Foster City, CA, USA.
Neeru BhardwajGilead Sciences Inc., Foster City, CA, USA.
Anuj GaggarGilead Sciences Inc., Foster City, CA, USA.
Li LiGilead Sciences Inc., Foster City, CA, USA.
Hongmei MoGilead Sciences Inc., Foster City, CA, USA.
Becket FeierbachGilead Sciences Inc., Foster City, CA, USA.
Gilead Sciences (United States) · USChinese University of Hong Kong · HKHôpital Beaujon · FRVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: HBV infects over 257 million people worldwide and is associated with the development of hepatocellular carcinoma (HCC). Integration of HBV DNA into the host genome is likely a key driver of HCC oncogenesis. Here, we utilise targeted long-read sequencing to determine the structure of HBV DNA integrations as well as full isoform information of HBV mRNA with more accurate quantification than traditional next generation sequencing platforms. Methods: DNA and RNA were isolated from fresh frozen liver biopsies collected within the GS-US-174-0149 clinical trial. A pan-genotypic panel of biotinylated oligos was developed to enrich for HBV sequences from sheared genomic DNA (∼7 kb) and full-length cDNA libraries from poly-adenylated RNA. Samples were sequenced on the PacBio long-read platform and analysed using a custom bioinformatic pipeline. Results: HBV-targeted long-read DNA sequencing generated high coverage data spanning entire integrations. Strikingly, in 13 of 42 samples (31%) we were able to detect HBV sequences flanked by 2 different chromosomes, indicating a chromosomal translocation associated with HBV integration. Chromosomal translocations were unique to each biopsy sample, suggesting that each originated randomly, and in some cases had evidence of clonal expansion. Using targeted long-read RNA sequencing, we determined that upwards of 95% of all HBV transcripts in patients who are HBeAg-positive originate from cccDNA. In contrast, patients who are HBeAg-negative expressed mostly HBsAg from integrations. Conclusions: Targeted lso-Seq allowed for accurate quantitation of the HBV transcriptome and assignment of transcripts to either cccDNA or integration origins. The existence of multiple unique HBV-associated inter-chromosomal translocations in non-HCC CHB patient liver biopsies suggests a novel mechanism with mutagenic potential that may contribute to progression to HCC. Lay summary: Fresh frozen liver biopsies from patients infected with HBV were subjected to targeted long-read RNA and DNA sequencing. Long-read RNA sequencing captures entire HBV transcripts in a single read, allowing for resolution of overlapping transcripts from the HBV genome. This resolution allowed us to quantify the burden of transcription from integrations

Indexed as

cccDNA, covalently closed circular DNACCS, circular consensus sequenceCHB, chronic hepatitis BChromosomal translocationsChronic HBVClonal expansioncontig, contiguous sequenceDNA-Seq, DNA sequencingDR1, direct repeat 1dslDNA, double-stranded linear DNAFFPE, formalin-fixed paraffin-embeddedgDNA, genomic DNAHCC, hepatocellular carcinomaIntegrated HBV DNALong-read sequencingN/A, nucleos(t)ide analogueNHEJ, non-homologous end-joiningPEG-IFNα, pegylated interferon αpgRNA, pre-genomic RNArcDNA, relaxed circular DNARIN, RNA integrity numberRNA-Seq, RNA sequencingtargeted Iso-Seq, targeted long-read RNA-sequencingTargeted sequencingTDF, tenofovir disoproxil fumarateTERT, telomerase reverse transcriptaseWGS, whole genome sequencing

Identifiers

PMID35295767
PMCPMC8918852
OpenAlexW4213038342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.